Huntington's disease is a dubious disease in the field of the nervous system, with complex clinical outcomes that often involve multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of Huntington's disease requires a combination of clinical outcomes, imaging checks, laboratory checks and pathological reactivity checks.
The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Individual treatment plans for treatment and management of Huntington's disease are often developed, including multi-dimensional management of drug therapy, rehabilitation plans, and regular follow-up. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neural system disorders that have been difficult to treat have been significantly improved.
Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment to changes in disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of Huntington's disease. The platform serves a team of domestic and foreign authorities in the field of neural systems in China, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.